Seroatlas · Human Serome Atlas

EXOC3L2

Exocyst complex component 3-like protein 2

Also known as: EX3L2_HUMAN

Cross-references: UniProt · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q2M3D2
Gene
EXOC3L2
Canonical length
802 aa
Protein class
Predicted intracellular proteins

OverviewNCBI Gene

No narrative summary is available for EXOC3L2 in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

802 residues, UniProt reviewed canonical sequence.

>Q2M3D2|EXOC3L2
     1  MPILKNLGVS DPKVPRAGTL PLRSSRNPFE EVSGLEEEEA GELGSLPNGT SCRRRATLEK
    61  LAGLAPFRLG WAPGRRAGSP GDGQPRSFLG RVLVPGIRRS SADFGLLARL HGTRAHGDEE
   121  AAGEAARRLA FLRLGRGSKP QRASLAERVV PAGEAAPEPP PKVPEPPKMK EPLSVLEILS
   181  LIQQRELARA DEHILELEAE ELAPSRGGAP GPPKAEGAGG GRRARDVALL YEALQRELWA
   241  LVRETLAGPG PGACAGAGAV AQLGQVLVQE EAADGRRGPG AARKLRARWA EAVARAARER
   301  LEAAAPGAPG GLAGQLEALR ARLLEDMAVV RGRLAPAYPA GLGAFGVYLR GYHGALAEWL
   361  GASARRRLPL ADRYALLHWH NQVYPREVLG LVDMAALENG ELGPLLSPGT LRGLEDECVT
   421  DVKAQTRAAL LRVLQEDEEH WGSLEDQPSS LAQDVCELLE EHTERAPRIS QEFGERMAHC
   481  CLGGLAEFLQ SFQQRVERFH ENPAVREMLP DTYISKTIAL VNCGPPLRAL AERLARVGPP
   541  ESEPAREASA SALDHVTRLC HRVVANLLFQ ELQPHFNKLM RRKWLSSPEA LDGIVGTLGA
   601  QALALRRMQD EPYQALVAEL HRRALVEYVR PLLRGRLRCS SARTRSRVAG RLREDAAQLQ
   661  RLFRRLESQA SWLDAVVPHL AEVMQLEDTP SIQVEVGVLV RDYPDIRQKH VAALLDIRGL
   721  RNTAARQEIL AVARDLELSE EGALSPPRDR AFFADIPVPR PSFCLSLPLF LGRLPLSRLA
   781  RPSLACLPRP RPPSLARPRA QR

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against EXOC3L2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.41
Highest tissue expression
21 nTPM

Expression across tissuesHPA

Tissue

  • kidney: 21 nTPM
  • thyroid gland: 18 nTPM
  • adrenal gland: 9 nTPM
  • spleen: 8.7 nTPM
  • pituitary gland: 5.4 nTPM
  • prostate: 5.3 nTPM

Single-cell type

  • megakaryocytes: 80 nCPM
  • vascular endothelial cells: 60 nCPM
  • oocytes: 46 nCPM
  • platelets: 33 nCPM
  • megakaryocyte progenitors: 27 nCPM
  • undifferentiated spermatogonia: 17 nCPM

Immune cell

  • basophil: 0.3 nTPM
  • neutrophil: 0.3 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM

Brain region

  • choroid plexus: 4.8 nTPM
  • medulla oblongata: 3 nTPM
  • basal ganglia: 2.7 nTPM
  • white matter: 2.7 nTPM
  • midbrain: 2.6 nTPM
  • pons: 2.5 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about EXOC3L2.

Disease | AllUniProt

Conditions EXOC3L2 is implicated in, by any mechanism.

Disease | GeneticClinVar

3 pathogenic / likely-pathogenic of 138 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.43
gnomAD pLI
0.76
gnomAD missense Z
0.66
DepMap mean gene effect
0
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads EXOC3L2 as an antibody target. Whether an autoantibody or antibody against EXOC3L2 could matter depends on whether native EXOC3L2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

EXOC3L2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label EXOC3L2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/EXOC3L2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...